Correlation Between Moberg Pharma and I Tech
Can any of the company-specific risk be diversified away by investing in both Moberg Pharma and I Tech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moberg Pharma and I Tech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moberg Pharma AB and I Tech, you can compare the effects of market volatilities on Moberg Pharma and I Tech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moberg Pharma with a short position of I Tech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moberg Pharma and I Tech.
Diversification Opportunities for Moberg Pharma and I Tech
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Moberg and ITECH is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Moberg Pharma AB and I Tech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Tech and Moberg Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moberg Pharma AB are associated (or correlated) with I Tech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Tech has no effect on the direction of Moberg Pharma i.e., Moberg Pharma and I Tech go up and down completely randomly.
Pair Corralation between Moberg Pharma and I Tech
Assuming the 90 days trading horizon Moberg Pharma AB is expected to generate 2.04 times more return on investment than I Tech. However, Moberg Pharma is 2.04 times more volatile than I Tech. It trades about 0.03 of its potential returns per unit of risk. I Tech is currently generating about 0.03 per unit of risk. If you would invest 1,613 in Moberg Pharma AB on September 24, 2024 and sell it today you would lose (555.00) from holding Moberg Pharma AB or give up 34.41% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Moberg Pharma AB vs. I Tech
Performance |
Timeline |
Moberg Pharma AB |
I Tech |
Moberg Pharma and I Tech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Moberg Pharma and I Tech
The main advantage of trading using opposite Moberg Pharma and I Tech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moberg Pharma position performs unexpectedly, I Tech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Tech will offset losses from the drop in I Tech's long position.Moberg Pharma vs. Mendus AB | Moberg Pharma vs. BioInvent International AB | Moberg Pharma vs. Orexo AB | Moberg Pharma vs. Oncopeptides AB |
I Tech vs. BioInvent International AB | I Tech vs. Alligator Bioscience AB | I Tech vs. Moberg Pharma AB | I Tech vs. Oncopeptides AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |